Longitudinal Assessment of Vitamin D Status across Trimesters of Pregnancy.
25(OH)D
25-hydroxyvitamin D
pregnancy
supplements
vitamin D
vitamin D intake
vitamin D status
Journal
The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243
Informations de publication
Date de publication:
01 07 2021
01 07 2021
Historique:
received:
25
11
2020
revised:
22
12
2020
accepted:
17
02
2021
pubmed:
9
4
2021
medline:
29
1
2022
entrez:
8
4
2021
Statut:
ppublish
Résumé
The evolution of vitamin D status across pregnancy trimesters and its association with prepregnancy body mass index (ppBMI; in kg/m2) remain unclear. We aimed to 1) assess trimester-specific serum total 25-hydroxyvitamin D [25(OH)D] concentrations, 2) compare those concentrations between ppBMI categories, and 3) examine associations between 25(OH)D concentrations, ppBMI, and vitamin D intake. As part of a prospective cohort study, 79 pregnant women with a mean age of 32.1 y and ppBMI of 25.7 kg/m2 were recruited in their first trimester (average 9.3 weeks of gestation). Each trimester, vitamin D intake was assessed by 3 Web-based 24-h recalls and a Web questionnaire on supplement use. Serum total 25(OH)D was measured by LC-tandem MS. Repeated-measures ANOVA was performed to assess the evolution of 25(OH)D concentrations across trimesters of pregnancy and comparisons of 25(OH)D concentrations between ppBMI categories were assessed by 1-factor ANOVAs. Stepwise regression analyses were used to identify determinants of 25(OH)D concentrations in the third trimester. Mean ± SD serum total 25(OH)D concentrations increased across trimesters, even after adjustments for ppBMI, seasonal variation, and vitamin D intake from supplements (67.5 ± 20.4, 86.5 ± 30.9, and 88.3 ± 29.0 nmol/L at mean ± SD 12.6 ± 0.8, 22.5 ± 0.8, and 33.0 ± 0.6 weeks of gestation, respectively; P < 0.0001). In the first and third trimesters, women with a ppBMI ≥30 had lower serum total 25(OH)D concentrations than women with a ppBMI <25 (P < 0.05); however, most had concentrations >40nmol/L by the second trimester. Vitamin D intake from supplements was the strongest determinant of third-trimester serum total 25(OH)D concentrations (r2 = 0.246, β = 0.51; P < 0.0001). There was an increase in serum total 25(OH)D concentrations across trimesters, independent of ppBMI, seasonal variation, and vitamin D intake from supplements. Almost all women had serum total 25(OH)D concentrations over the 40- and 50-nmol/L thresholds, thus our study supports the prenatal use of a multivitamin across pregnancy.
Sections du résumé
BACKGROUND
The evolution of vitamin D status across pregnancy trimesters and its association with prepregnancy body mass index (ppBMI; in kg/m2) remain unclear.
OBJECTIVES
We aimed to 1) assess trimester-specific serum total 25-hydroxyvitamin D [25(OH)D] concentrations, 2) compare those concentrations between ppBMI categories, and 3) examine associations between 25(OH)D concentrations, ppBMI, and vitamin D intake.
METHODS
As part of a prospective cohort study, 79 pregnant women with a mean age of 32.1 y and ppBMI of 25.7 kg/m2 were recruited in their first trimester (average 9.3 weeks of gestation). Each trimester, vitamin D intake was assessed by 3 Web-based 24-h recalls and a Web questionnaire on supplement use. Serum total 25(OH)D was measured by LC-tandem MS. Repeated-measures ANOVA was performed to assess the evolution of 25(OH)D concentrations across trimesters of pregnancy and comparisons of 25(OH)D concentrations between ppBMI categories were assessed by 1-factor ANOVAs. Stepwise regression analyses were used to identify determinants of 25(OH)D concentrations in the third trimester.
RESULTS
Mean ± SD serum total 25(OH)D concentrations increased across trimesters, even after adjustments for ppBMI, seasonal variation, and vitamin D intake from supplements (67.5 ± 20.4, 86.5 ± 30.9, and 88.3 ± 29.0 nmol/L at mean ± SD 12.6 ± 0.8, 22.5 ± 0.8, and 33.0 ± 0.6 weeks of gestation, respectively; P < 0.0001). In the first and third trimesters, women with a ppBMI ≥30 had lower serum total 25(OH)D concentrations than women with a ppBMI <25 (P < 0.05); however, most had concentrations >40nmol/L by the second trimester. Vitamin D intake from supplements was the strongest determinant of third-trimester serum total 25(OH)D concentrations (r2 = 0.246, β = 0.51; P < 0.0001).
CONCLUSIONS
There was an increase in serum total 25(OH)D concentrations across trimesters, independent of ppBMI, seasonal variation, and vitamin D intake from supplements. Almost all women had serum total 25(OH)D concentrations over the 40- and 50-nmol/L thresholds, thus our study supports the prenatal use of a multivitamin across pregnancy.
Identifiants
pubmed: 33830266
pii: S0022-3166(22)00236-X
doi: 10.1093/jn/nxab060
pmc: PMC8245879
doi:
Substances chimiques
Vitamins
0
Vitamin D
1406-16-2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1937-1946Subventions
Organisme : CIHR
ID : GSD-167043
Pays : Canada
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.
Références
J Clin Endocrinol Metab. 2013 Aug;98(8):3165-73
pubmed: 23783101
Nutr Rev. 2013 Feb;71(2):118-32
pubmed: 23356639
J Endocrinol Invest. 2006 Apr;29(4):303-7
pubmed: 16699295
Early Hum Dev. 2015 Nov;91(11):623-8
pubmed: 26363942
BMC Pregnancy Childbirth. 2018 Apr 23;18(1):112
pubmed: 29685127
Matern Child Health J. 2014 Sep;18(7):1667-74
pubmed: 24337814
J Am Diet Assoc. 2000 Nov;100(11):1334-40
pubmed: 11103655
Ginekol Pol. 2013 May;84(5):363-7
pubmed: 23819402
Acta Diabetol. 2014 Aug;51(4):609-16
pubmed: 24526261
Clin Nutr. 2020 May;39(5):1432-1439
pubmed: 31229327
J Obstet Gynaecol Res. 2017 Feb;43(2):247-256
pubmed: 28150405
Clin Endocrinol (Oxf). 2013 Sep;79(3):333-41
pubmed: 23305099
J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
pubmed: 21646368
Br J Gen Pract. 2017 Sep;67(662):423-424
pubmed: 28860301
PLoS One. 2012;7(6):e38818
pubmed: 22701717
Nutrients. 2016 May 20;8(5):
pubmed: 27213444
PLoS One. 2016 Jul 01;11(7):e0157262
pubmed: 27367800
Clin Endocrinol (Oxf). 2016 May;84(5):680-6
pubmed: 26641010
PLoS One. 2017 Mar 17;12(3):e0173605
pubmed: 28306725
Cochrane Database Syst Rev. 2019 Oct 03;10:CD013446
pubmed: 31581312
Eur J Nutr. 2018 Apr;57(3):1059-1072
pubmed: 28353072
Arch Gynecol Obstet. 2016 May;293(5):959-66
pubmed: 26825733
Obes Rev. 2015 Apr;16(4):341-9
pubmed: 25688659
Am J Clin Nutr. 2017 Aug;106(2):541-548
pubmed: 28615265
Nutrients. 2016 Nov 15;8(11):
pubmed: 27854276
Public Health Nutr. 2018 Oct;21(15):2744-2752
pubmed: 29976261
Endocr Rev. 1997 Dec;18(6):832-72
pubmed: 9408745
Ir Med J. 2008 Sep;101(8):240, 242-3
pubmed: 18990953
Int J Vitam Nutr Res. 2018 Jun;88(3-4):176-189
pubmed: 30747608
Can J Public Health. 2016 Dec 27;107(4-5):e410-e416
pubmed: 28026707
Nutrients. 2019 Jan 04;11(1):
pubmed: 30621126
Med Sci Sports Exerc. 2004 Oct;36(10):1750-60
pubmed: 15595297
J Matern Fetal Neonatal Med. 2018 Jan;31(2):158-163
pubmed: 28043188
J Clin Endocrinol Metab. 1988 Aug;67(2):373-8
pubmed: 2839537
Clin Endocrinol (Oxf). 2013 Jan;78(1):126-33
pubmed: 22702488
J Nutr Sci Vitaminol (Tokyo). 2014;60(4):269-75
pubmed: 25297616
Am J Clin Nutr. 2018 Jul 1;108(1):77-91
pubmed: 29878035
J Nutr. 2007 Nov;137(11):2437-42
pubmed: 17951482
Nutrients. 2018 Mar 29;10(4):
pubmed: 29596362
Nutrients. 2018 Nov 02;10(11):
pubmed: 30400155
Clin Biochem. 2013 Oct;46(15):1489-92
pubmed: 23726811
J Matern Fetal Neonatal Med. 2019 Aug;32(15):2580-2590
pubmed: 29447091
Nutrients. 2019 Jan 09;11(1):
pubmed: 30634435
BJOG. 2012 Jun;119(7):832-9
pubmed: 22462640
Can J Public Health. 2011 Jul-Aug;102(4):308-12
pubmed: 21913590
J Endocrinol Invest. 2007 Sep;30(8):653-8
pubmed: 17923796